October 3rd 2022
This week's edition of the Mainstream Patient features stories about recommended acne solutions from dermatologists, Latinx-owned beauty brands, the latest skin care trend of "skin energy," and more.
September 15th 2022
Burst CME: Improving Outcomes for Your Patient with Vitiligo
View More
Burst CME: Improving Outcomes for Your Patient with Vitiligo
View More
Individualizing Treatment in Moderate-to-Severe Atopic Dermatitis through Improved Clinician-Patient Communication
View More
Clinical ConsultationsTM: Focusing on Fabry Disease in Females: Individualizing Diagnostic and Counseling Plans to Improve Long-Term Outcomes
View More
Individualizing Treatment in Moderate-to-Severe Atopic Dermatitis through Improved Clinician-Patient Communication
View More
22nd Annual International Congress on the Future of Breast Cancer® East
View More
22nd Annual International Congress on the Future of Breast Cancer® East
View More
4th Annual International Congress on the Future of Women’s Health™
07/22/2023
View More
22nd Annual International Congress on the Future of Breast Cancer® West
View More
22nd Annual International Congress on the Future of Breast Cancer® West
View More
An Animated View of Alopecia Areata to Advance Our Approaches to Patient Management
View More
An Animated View of Alopecia Areata to Advance Our Approaches to Patient Management
View More
6th Annual Advanced Practice Collaborative
09/08/2023-09/09/2023
View More
Advances in™ Hidradenitis Suppurativa (HS): Optimizing the Management Approach with Available and Emerging Treatments
View More
Advances in™ Hidradenitis Suppurativa (HS): Optimizing the Management Approach with Available and Emerging Treatments
View More
Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team
View More
Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team
View More
Medical Crossfire®: Diagnostic and Clinical Considerations in Cutaneous T-Cell Lymphoma for the Dermatologist and the Collaborative Cancer Team
View More
7th Annual New York Cardio-Endo-Renal Collaborative (NY CERC)
10/21/2023
View More
7th Annual New York Cardio-Endo-Renal Collaborative (NY CERC)
10/21/2023
View More
Best Practice in the Multidisciplinary Care of the Patient with HS
View More
Addressing Challenges in the Management of HS in Special Populations
View More
Best Practice in the Multidisciplinary Care of the Patient with HS
View More
Addressing Challenges in the Management of HS in Special Populations
View More
Clinical Conversations With the Cancer Care Team: Discussing the Impact of Social Inequities on Treatment Outcomes in Triple-Negative Breast Cancer
View More
Clinical Conversations With the Cancer Care Team: Discussing the Impact of Social Inequities on Treatment Outcomes in Triple-Negative Breast Cancer
View More
Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices
View More
Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices
View More
Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices
View More
Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices
View More
Estrogen's keratinocyte connection
September 1st 2002Los Angeles -- In an attempt to prove estrogen's unknown effect on keratinocytes, researchers presented in vitro data at the Society for Investigative Dermatology that suggest a direct link of the hormone to in vivo epidermal turnover and wound healing.
Derm drugs pose serious fetal risks
August 1st 2002New York - A number of drugs used commonly in dermatology have teratogenic potential, making careful screening and comprehensive and ongoing pregnancy prevention counseling a must when prescribing medications for female patients, Robyn Gmyrek, M.D., said.
Government takes pro Maine prescription position
August 1st 2002Although the Bush Administration, in the person of the Solicitor General, filed a brief with the U.S. Supreme Court suggesting that it refuse to hear an appeal from the Pharmaceutical Research and Manufacturers of America (PhRMA) on Maine's Rx prescription law, the court agreed to hear the case.
Melanoma discovery quickens research pace
July 1st 2002Gene mutation a breakthrough, but much more testing neededThe identification of the BRAF gene mutation's presence in 66 percentof malignant melanomas received much fanfare last month, but physiciansstill are years shy of reaping the rewards of the discovery through diagnostictools and drug therapies.
Adjunctive approaches aid in acute wound healing
May 1st 2002New Orleans - Adjunctive therapies from occlusive dressings to growth factors and tissue-engineered skin can hasten and augment the healing of acute wounds, Robert S. Kirsner, M.D., said at the annual meeting of the American Academy of Dermatology.
BCC risk in rhinophyma patients should be taken into account
April 1st 2002New Orleans - Rhinophyma resection needs to be performed in a way that allows for postoperative histopathologic study, according to Luis A. Lopardo, MD, speaking here at the 60th annual meeting of the American Academy of Dermatology.
Modified Mohs recommended for LM/LMM
March 1st 2002Dallas - Modified Mohs micrographic surgery using immunohistochemicalstaining of frozen sections along with rush permanent sections may be thetreatment of choice for lentigo maligna and lentigo maligna melanoma, Lian-JieLi, M.D., said at the annual combined meeting of the American Society forDermatologic Surgery and the American College of Mohs Micrographic Surgeryand Cutaneous Oncology.
Novel vaccine promising in treatment of genital warts
February 1st 2002Baltimore - Phase II study results point to the potential roleof HspE7 as a safe and effective immunotherapeutic agent for the treatmentof genital warts and other HPV-related sexually transmitted diseases, KeertiV. Shah, M.D., said.